J&J Hard at Work on Additional COVID-19 Vaccines
Dimensions of Dental Hygiene
MARCH 20, 2021
Johnson & Johnson (J&J) is continuing to develop new COVID-19 vaccines to provide protection against a host of SARS-CoV-2 variants. Currently on the pharmaceutical giant’s agenda is creating a vaccine to combat the South African variant, B1351, which is more frequently found among young, healthy people and can cause more serious illness than the original strain of the novel coronavirus.
Let's personalize your content